Anti-Human RSV (Palivizumab Biosimilar)
Product Details
| Clone | Palivizumab |
|---|
| Application | Flow cytometry, animal model study |
|---|
| Host Species | Mammalian cells |
|---|
| Format | Liquid |
|---|
| Product Description | Palivizumab Biosimilar, Endotoxin 0.05 EU/mg |
|---|
| Isotype | Human IgG1 |
|---|
| Regulatory Status | RUO |
|---|
| Clonality | Recombinant |
|---|
| Immunogen | Respiratory Syncytial Virus F protein |
|---|
| Species specificity | Human |
|---|
| Purity | >95% by reducing SDS-PAGE |
|---|
| Grade | In vivo |
|---|
| Storage Conditions | 4ºC |
|---|
| Maximal Shelf Life | 12 months |
|---|
Data Sheets
Anti-Human RSV (Palivizumab Biosimilar) TDS
